MRC Clinical Trials Unit Session - 23rd Annual Conference of BHIVA

The motion: This house believes that efavirenz should remain as an option to treat HIV in the UK

Dr Sarah Pett For the motion: Dr Sarah Pett
MRC Clinical Trials Unit, London

Dr Alejandro Arenas-Pinto Against the motion: Dr Alejandro Arenas-Pinto
MRC Clinical Trials Unit, London
 

Click here to go back to all presentations.